German beer sales fell 6.0% to 7.8 bn liters in 2025 — worst since 1993, first time below 8 bn liters. Structural drivers: aging population, health awareness, price sensitivity, growth in alcohol-free (+7.6%). Even at a much slower –2.5% rate in 2026, total sales would hit ~7.61 bn liters. Breaching the 7.6 bn mark requires only ~2.6% further decline — well within the trend corridor.
Gerolsteiner (GmbH, private) posted ~€349m revenue (+2.7%) and 8.3m hl volume (+3.4%) in 2025 — outpacing the overall market. Germany's mineral water market leader (10.2% revenue share) benefits from the premiumization trend, still water growth, and a strong sustainability/PPWR-aligned positioning. Reaching €360m requires ~3.2% growth — in line with recent trajectory.
Germany's federal government introduced a draft sugar levy bill with tiered rates on soft drinks, cola, iced tea, and energy drinks (est. €450m annual revenue, effective 2027). Support from the German Diabetes Society (DDG declares 'Die Zuckersteuer kommt'), physicians' associations, Foodwatch. Opposition: 300+ companies including Coca-Cola, PepsiCo, Red Bull (as of July 2, 2026). CDU/CSU traditionally industry-friendly, but SPD coalition pressure and health lobbying are significant. Parliamentary passage in 2026 is plausible but politically uncertain.
AG Barr trades at 633p on July 11, 2026; 660p represents +4.3% by year-end. Strong fundamental momentum: H1 FY2027 with +20.1% adjusted PBT (July 2026), FY2026 EPS 42p (+17%), revenue £437M. Analyst average target 771p (+22%). Forward PE 13.2 – moderate valuation. Headwinds: UK consumer sector pressure, UK SDIL rate increase from April 2026. No prediction market; own estimate 58%.
Heineken HEIA is estimated at ~€76/share (derived from HEINY ADR ~$43 at 0.5:1 ratio, EUR/USD 1.13). Reaching €85 by year-end requires ~+12%. Catalysts: (1) organic revenue growth >4% consensus for 2026, (2) FIFA World Cup 2026 beer consumption boost – Heineken is official WC beer partner, (3) potential re-rating of European consumer staples as ECB rate cycle evolves. Headwinds: Hormuz-driven energy cost inflation; weak Chinese consumer demand.
Red Bull recorded a landmark year in 2025 with 13.969 billion cans (+10.2% vs. 2024) and group revenue of €12.196bn (+8.6%). Reaching 14 billion cans in 2026 requires only +0.2% growth vs. 2025 — easily achieved even at the conservative 3–5% growth analysts expect. Red Bull is present in 178 countries, with strong momentum in Asia and Latin America; the 2026 FIFA World Cup partnership provides additional uplift. Annual 2026 figures will typically be published in spring 2027. No Polymarket quote available.
The existing open prediction sets Carlsberg B above 950 DKK on July 18, 2026 — so current price is near 950 DKK. A year-end target of 1,000 DKK implies ~+5% by December 31. Carlsberg is a defensive brewer with robust EUR/DKK effect and targeted organic growth >2% in FY2026. H2 catalysts: H1 results report (August 5, 2026), possible share buyback, selective EM M&A (Asia, Africa). No Polymarket market found; calibrated via peer P/E (historically 15–18×).
Heineken benefits in 2026 from a strong FIFA World Cup H1 impulse in core markets (Mexico, Brazil, Vietnam, Netherlands). Sector calibration point: Carlsberg achieved 3.6% organic revenue growth in Q1 2026 and raised FY2026 guidance to 2–6%. Heineken H1 2026 results (August 5, 2026) are separately predicted by Cassandra at >3%. For full-year above 4.0%, H2 must show similar momentum — plausible given expected Nigeria recovery and sustainably strong Vietnam performance. Annual results typically February 2027. No Polymarket/Kalshi market found.
German beer sales fell 3.9% year-over-year in January to May 2026 (30.56M hl); May 2026 alone dropped 7.5% (6.96M hl), with beer mixtures down 14.9%. 2025 was already a sharp contraction year at −6% vs. 2024. The short-term FIFA World Cup boost (June–July 2026, Budweiser/AB InBev sponsorship) will likely only temporarily moderate the trend. Structural factors dominate: demographics, alcohol-reduction trends and brewery closures such as Herforder Brauerei (Warsteiner, by August 2026). The case for a full-year >5% decline rests on: (a) strongly negative May despite favourable weather, (b) persistently weak beer mixtures, (c) ongoing capacity reduction. No Polymarket market available; 52% probability.
Brown-Forman (Jack Daniel's ~40% of revenue, Woodford Reserve, Old Forester) faces the same global premium whiskey downturn as Diageo and Pernod Ricard: distributor destocking, stagnant US domestic demand, weakness in Europe and Asia-Pacific. Fiscal year runs May–April; H1 FY2027 covers May–October 2026, results typically released in early December. IWSR 2026 confirms ongoing global American whiskey volume weakness. Open platform predictions for both Diageo and Pernod Ricard show the same organic decline pattern. No Polymarket market found for BF.B. Assessment: ~65% probability of organic decline.
Brown-Forman (Jack Daniel's, Woodford Reserve, Old Forester) faces ongoing structural headwinds: GLP-1 drugs suppress alcohol consumption, post-Covid normalization weighs on the premium segment, economic uncertainty in Europe and the US. Peer comparison: Diageo, Pernod Ricard, and Rémy Cointreau are all predicted to show organic revenue declines on the Cassandra platform — an industry-wide trend. Brown-Forman already reported declining Jack Daniel's US volumes in Q4 FY2026 (Feb–Apr 2026). No Polymarket market for BF.B individual results. Q2 FY2027 (Aug–Oct 2026) with publication approximately December 2026.
Brown-Forman's Q2 FY2026 (August–October 2025) showed revenue declining to USD 1.036 billion (from ~USD 1.11 billion prior year) and EPS falling from $0.55 to $0.47. The company confirmed 'every major spirits category is declining except RTD beverages' and cited 'deteriorating market conditions in China and weaker-than-expected US rebound.' BF has heavy exposure to whisky (Jack Daniel's, Woodford Reserve) – categories facing persistent structural headwinds. Rémy Cointreau's –11% organic Q2 FY2026 miss provides a broader industry indicator. No direct market odds.
Q1 FY2027 (April–June 2026) already posted +1.3% organic growth, led by Cognac (+7.7%) driven by strong APAC (rest of Asia in double digits). Management confirmed the full-year guidance (return to sustainable organic growth, progressively strengthening). Q2 benefits from pre-Christmas inventory restocking. Risk: continued Americas weakness (US/Canada destocking). Calibrated at 65% accounting for possible Q2 Americas softness.
Rémy Cointreau – the leader in Cognac (Rémy Martin) and ultra-premium spirits – has suffered since 2023 from weak Chinese demand due to Chinese anti-dumping duties on European brandy and sluggish US consumer spending in the premium segment. In FY2025/26 the company reported organic declines of more than 6% in consecutive half-years. For April–September 2026, China trade tensions and US tariff uncertainty remain a drag; full normalization is not expected before FY2027/28. No Polymarket market; own estimate 62% based on the sustained structural decline.
Carlsberg is one of the structurally most stable major beverage groups: its core beer portfolio is less exposed to the premium spirits decline (Rémy Cointreau, Campari, Brown-Forman all in decline). Carlsberg communicated an organic growth target of 4–8% for FY2025 and benefits from price increases in Western Europe and volume growth in Vietnam, Laos and India. A figure above 3% for the first nine months of 2026 is consistent with the company's guidance philosophy. Political risk: Russia exposure (Baltika sale completed in 2023) no longer acts as a drag.
Campari Group reported organic net revenue growth of +2.9% in Q1 FY2026 (January–March 2026) — well above the 2.5% threshold. The full-year guidance calls for approximately 3% organic growth. Core brands Aperol (European growth driver), Campari, and Wild Turkey show stable demand. US import tariff headwind was revised down to an estimated €20 million for FY2026 (from initially €30 million). H2 momentum benefits from the summer cocktail season. No specific Polymarket market; estimate based on Q1 result and company outlook.
Rémy Cointreau recorded consistent double-digit organic revenue declines in FY2024/25 and FY2025/26, primarily due to collapsing Chinese cognac demand (Rémy Martin is the largest revenue driver) and US import tariffs on European spirits. These structural headwinds — declining Chinese appetite for premium spirits, US tariff uncertainty, GLP-1-driven alcohol consumption reduction in North America — persist for H1 FY2026/27 (April–September 2026). A return to positive organic growth would be a positive surprise (possible with Chinese stimulus or tariff rollback), but is not the base case. No Polymarket/Kalshi market identified; estimate based on historical results and industry trends.
Campari Group reported H1 2026 organic revenue growth of +2.7% (net sales €1.51bn) and raised FY2026 guidance to at least +3.0% organic. Aperol (+3.3%) and Campari brand (+2.3%) were key drivers in H1. A >2.0% target for the 9-month period implies moderate Q3 deceleration — well supported by current guidance. In contrast to Diageo and Pernod Ricard (predicted declines), Campari benefits from the European aperitif segment boom. No conflict with existing predictions.
Rémy Cointreau derives more than 85% of revenues from Cognac, making it more exposed to Chinese retaliatory tariffs (25% on European spirits since April 2024) than more diversified peers. In FY2025 and FY2026, the company already posted double-digit organic declines. A recovery for H1 FY2027 (April–September 2026) is implausible: tariffs persist, and Chinese cognac imports from Europe fell approximately 38% YoY in H1 2025 (BNIC data). Additionally, Trump import tariffs weigh on the US premium spirits market. For comparison, open predictions on this platform expect Pernod Ricard (more diversified) at >–3% and Diageo at >–1.5% organic decline — Rémy is structurally more vulnerable. No Polymarket market available.
Rémy Cointreau achieved organic stabilisation in FY2025-26 after years of steep declines (+0.2% total, cognac –0.5%). In Q4 FY2025-26 and Q1 FY2026-27, cognac is already driving a return to growth; the company states it is 'confident in returning to growth'. Premiumised demand trends in Europe and early China rebound support the scenario. Headwinds: US import tariffs on French cognac dampen US margin and reported growth (currency effects). Consensus estimates imply approximately 50–55% probability of >2% organic growth in H1.